Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solventum Corporation Common Stock (NY:SOLV)

73.33 +0.46 (+0.63%)
Streaming Delayed Price Updated: 11:12 AM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 Next >
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)... 
Via StockStory
Topics Artificial Intelligence Economy
Here's What 3M's Big News Means to Investors
Via The Motley Fool
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy
Is 3M Stock a Buy Now?
The manufacturing conglomerate is slowly turning a corner. 
Via The Motley Fool
What Analysts Are Saying About Solventum Stock
 
Via Benzinga
Earnings Scheduled For February 27, 2025
 
Via Benzinga
3M Stock: Buy, Sell, or Hold?
Via The Motley Fool
5 Analysts Have This To Say About Solventum
 
Via Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Why Solventum (SOLV) Stock Is Down Today
Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed. On the other... 
Via StockStory
Topics Initial Public Offering
Friday's session: top gainers and losers in the S&P500 index
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
Critical Insights From Solventum Analyst Ratings: What You Need To Know
 
Via Benzinga
Which S&P500 stocks are gapping on Friday?
Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Friday's pre-market session: top gainers and losers in the S&P500 index
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
Solventum: Q4 EPS Beats, Cash Flow Dips
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures. 
Via The Motley Fool
Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per... 
Via StockStory
Topics Artificial Intelligence Economy
Trian Comments on Solventum’s Sale of its Purification & Filtration Business
From Trian Fund Management, L.P.
Via GlobeNewswire
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
Solventum Shares Are Up Today: What's Going On?
Solventum shares are trading higher Tuesday after the company announced it will sell its purification and filtration business to Thermo Fisher for $4.1 billion in cash. 
Via Benzinga
Which S&P500 stocks are moving on Tuesday?
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion
Thermo Fisher will acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction portfolio with expected long-term growth. 
Via Benzinga
3 Reasons to Sell SOLV and 1 Stock to Buy Instead
Solventum has had an impressive run over the past six months as its shares have beaten the S&P 500 by 15.9%. The stock now trades at $74.24, marking a 24.9% gain. This was partly due to its solid... 
Via StockStory
Topics Stocks
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors
From Ampersand Biomedicines
Via GlobeNewswire
Where Will 3M Stock Be in 3 Years?
This former Dividend King isn't out of the woods yet. 
Via The Motley Fool
Trian Issues Open Letter to Solventum Shareholders
From Trian Fund Management, L.P.
Via GlobeNewswire
8 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Honeywell Pops As It Mulls This Move Echoing GE Aerospace
A standalone Honeywell aerospace business could be worth up to $120 billion. 
Via Investor's Business Daily
Nelson Peltz's Trian Fund Management Reshaped Portfolio Ahead Of Presidential Election
Trian Fund Management reshaped its portfolio in Q3. The moves come as Donald Trump's election victory is expected to bring significant economic policy shifts. 
Via Benzinga
Topics Government
The Second-Best Dow Jones Stock Of 2024 Dives After Earnings Beat
3M stock, Dow Jones Industrial Average component, flirted with a breakout on Tuesday morning after reporting better than expected earnings. 
Via Investor's Business Daily
Topics Stocks
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.